Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 70756-447

This text shows a chart illustrating the percentage reduction in CPS rate for patients treated with Divalproex sodium compared to Placebo. It also shows the percentage of patients who experienced improvement, no change, or worsening during the treatment.*

This text provides information on the reduction in CPS rate based on different doses. It includes a comparison between high and low doses, with a breakdown of the percentage of patients experiencing improvement, no change, or worsening. The data suggests a 50% reduction in CPS rate for the given doses.*

This text is a description of Divalproex Sodium Delayed-Release Capsules, USP. It includes information such as dosage, storage instructions, product identification, and details on how to administer the medication. The text also mentions the importance of reading the Medication Guide provided to each patient and keeping the medication out of reach of children. Additionally, it provides details on the manufacturer and a code reference.*

This is a description of Divalproex Sodium capsules manufactured by Lifestar Pharma LLC. Each capsule contains 125 mg of valproic acid and is a delayed-release product from Taiwan. The capsules are light blue to blue transparent caps with off-white to white opaque bodies, printed with LS on the cap and 447 on the body for identification. It is recommended to store the capsules at 20°C to 25°C. The capsules can be swallowed whole or opened with contents placed on food for administration. Patients are advised to refer to the package insert for full prescribing information and keep the medication out of reach of children. Each bottle contains 100 capsules for prescription use only.*

This is a description of Divalproex Sodium Delayed-Release Capsules, USP. Each capsule contains Divalproex sodium, USP equivalent to valproic acid at a strength of 125 mg. The medication guide is provided separately to each patient. The capsules are light blue to blue transparent on the cap and off white to white opaque on the body, with LS printed on the cap and 447 on the body for product identification. The medication should be stored at 20°C to 25°C (68°F to 77°F). The capsule can be swallowed whole or opened with the contents placed on food for administration. The full prescribing information is available in the package insert. Keep the medication out of reach of children. The product is manufactured for Lifestar Pharma LLC in Taiwan and the container is not intended for household use. Please visit lifestarpharma.com/medguide/divalproexsodiumdrcapstles.pdf or scan the QR code to access the Medication Guide.*

This description provides information about Divalproex Sodium Delayed-Release Capsules, USP. Each capsule contains Divalproex sodium, USP equivalent to valproic acid 125 mg. The capsules have a light blue to blue transparent cap and an off-white to white opaque body. They are imprinted with LS on the cap and 447 on the body for identification. The medication guide should be provided separately to each patient. The capsules should be stored at 20°C to 25°C (68°F to 77°F) in a USP tight, light-resistant container. The capsules can be swallowed whole or opened to sprinkle the contents on food for administration. It also emphasizes keeping the medication out of the reach of children. For more detailed prescribing information, refer to the package insert and website provided.*